IQVIA Digital Site Suite
-
An Introduction To One Home for Sites™
4/18/2024
This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.
-
One Home for Sites™ Partnership Program Guide
4/7/2024
Learn how your organization can become part of One Home for Sites, the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.
-
Study Start-Up Challenges: Hard Realities, Effective Strategies
3/13/2024
Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?
-
Introducing One Home for Sites™
2/8/2024
One Home for Sites is a vendor-agnostic, sponsor-agnostic, aggregation platform that provides single sign-on and more. Become part of the only industry-wide solution to site tech overload.
-
Accelerating Site Activation: Examples From Novartis And IQVIA
1/12/2024
As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.
-
Q&A With Novartis And IQVIA Study Start-Up Leaders
12/6/2023
The industry is measuring longer cycle times between protocol approval and site activation. Experts from Novartis and IQVIA share creative solutions to combat this trend and accelerate trial timelines.
-
Orchestrated Study Start-Up
10/16/2023
Learn how the IQVIA Investigator Site Portal reduces activation timelines and eliminates site frustrations by automating processes and providing complete oversight to study teams.
-
Practical Approaches To Faster Study Start-Ups
9/25/2023
Learn how teams can leverage organizational, procedural, and technological solutions to recapture valuable days, weeks, and even months in the activation timelines of research sites.
-
The Impact Of Clinical Trial Payments On Site-Sponsor Relationships
7/18/2023
The sponsor-site relationship relies on good faith, but late payments sow mistrust. Experts from BMS and CenExel Clinical Research explain how consolidating payment systems benefits both parties.
-
Crowdsource UAT: An Opportunity For Future Validation
6/28/2023
IQVIA, a leading health information technology and clinical research company, has introduced a new validation model for eTMF patterned after approaches used within the larger tech space.